| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $268K | +226.8% |
| R&D Expense | $14.2M | +29.3% |
| SG&A Expense | $16.8M | +19.1% |
| Operating Income | -$45.7M | -29.0% |
| Income Tax | $0 | — |
| Net Income | -$44.2M | -26.2% |
| EPS (Basic) | -$1.43 | +38.6% |
| EPS (Diluted) | -$1.43 | +38.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $29.9M | -49.3% |
| Short-term Investments | $52.8M | +14.4% |
| Accounts Receivable | $113K | +318.5% |
| Current Assets | $90.1M | -18.3% |
| Total Assets | $116.3M | -20.9% |
| Current Liabilities | $15.5M | +84.7% |
| Total Liabilities | $17.4M | +105.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$34.6M | -9.4% |
| Capital Expenditures | $791K | -39.3% |
| Investing Cash Flow | $5.6M | +106.7% |
| Financing Cash Flow | $5K | -100.0% |
| Free Cash Flow | -$35.4M | -7.5% |
| Stockholders' Equity |
| $98.9M |
| -28.6% |